X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28227) 28227
Book Review (3709) 3709
Publication (2062) 2062
Newsletter (737) 737
Newspaper Article (148) 148
Book Chapter (97) 97
Transcript (64) 64
Conference Proceeding (44) 44
Book / eBook (40) 40
Dissertation (28) 28
Magazine Article (14) 14
Government Document (3) 3
Trade Publication Article (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24608) 24608
humans (23728) 23728
oncology (13353) 13353
female (11948) 11948
male (11743) 11743
lung neoplasms - pathology (10070) 10070
middle aged (9755) 9755
cancer (8882) 8882
aged (8795) 8795
lung cancer, non-small cell (7840) 7840
lung cancer (7594) 7594
carcinoma, non-small-cell lung - pathology (6090) 6090
lung neoplasms - drug therapy (5961) 5961
chemotherapy (5943) 5943
adult (5734) 5734
cell line, tumor (5682) 5682
metastasis (5276) 5276
carcinoma, non-small-cell lung - drug therapy (5246) 5246
animals (4882) 4882
care and treatment (4573) 4573
apoptosis (4354) 4354
research (4317) 4317
prognosis (4250) 4250
expression (4094) 4094
tumors (4090) 4090
neoplasm staging (3967) 3967
non-small cell lung cancer (3733) 3733
respiratory system (3631) 3631
aged, 80 and over (3475) 3475
lung neoplasms - genetics (3462) 3462
analysis (3414) 3414
proteins (3384) 3384
carcinoma (3362) 3362
mice (3349) 3349
carcinoma, non-small-cell lung - secondary (3240) 3240
gene expression (3096) 3096
carcinoma, non-small-cell lung - genetics (3066) 3066
treatment outcome (3041) 3041
lung neoplasms - mortality (3038) 3038
survival (2906) 2906
lung neoplasms - metabolism (2868) 2868
health aspects (2864) 2864
genetic aspects (2725) 2725
cell biology (2635) 2635
carcinoma, non-small-cell lung - mortality (2595) 2595
antineoplastic combined chemotherapy protocols - therapeutic use (2517) 2517
surgery (2441) 2441
cell proliferation (2440) 2440
mutation (2371) 2371
development and progression (2365) 2365
rna, small interfering - genetics (2322) 2322
carcinoma, non-small-cell lung - metabolism (2278) 2278
cancer therapies (2262) 2262
kinases (2262) 2262
survival rate (2245) 2245
retrospective studies (2158) 2158
immunohistochemistry (2124) 2124
hematology, oncology and palliative medicine (2102) 2102
gene expression regulation, neoplastic (2053) 2053
biochemistry & molecular biology (2031) 2031
radiotherapy (2029) 2029
signal transduction (1990) 1990
antineoplastic agents - therapeutic use (1987) 1987
abridged index medicus (1947) 1947
lung cancer, small cell (1944) 1944
lung neoplasms - surgery (1892) 1892
brain neoplasms - secondary (1887) 1887
medicine (1863) 1863
rna interference (1828) 1828
therapy (1826) 1826
research article (1823) 1823
medicine & public health (1813) 1813
carcinoma, non-small-cell lung - surgery (1783) 1783
nsclc (1713) 1713
adenocarcinoma (1700) 1700
medical prognosis (1696) 1696
breast-cancer (1677) 1677
lung neoplasms - therapy (1674) 1674
pharmacology & pharmacy (1674) 1674
growth (1657) 1657
survival analysis (1655) 1655
oncology, experimental (1620) 1620
cell cycle (1612) 1612
patients (1602) 1602
activation (1598) 1598
article (1594) 1594
antineoplastic agents - pharmacology (1574) 1574
cisplatin (1574) 1574
follow-up studies (1570) 1570
gefitinib (1567) 1567
studies (1555) 1555
cell growth (1527) 1527
multidisciplinary sciences (1518) 1518
disease-free survival (1500) 1500
non-small cell lung carcinoma (1498) 1498
apoptosis - drug effects (1494) 1494
lymphatic metastasis (1493) 1493
proliferation (1484) 1484
pathology (1478) 1478
lung neoplasms - radiotherapy (1463) 1463
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (32) 32
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28346) 28346
Japanese (222) 222
French (198) 198
German (142) 142
Chinese (140) 140
Spanish (73) 73
Polish (46) 46
Italian (40) 40
Russian (36) 36
Korean (14) 14
Dutch (11) 11
Danish (10) 10
Turkish (9) 9
Czech (7) 7
Hungarian (7) 7
Serbian (4) 4
Croatian (3) 3
Hebrew (3) 3
Romanian (3) 3
Icelandic (2) 2
Portuguese (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 3, pp. 655 - 661
Purpose Controversy endures regarding the optimal treatment of patients with brain metastases (BMs). Debate persists, despite many randomized trials, perhaps... 
Radiology | Hematology, Oncology and Palliative Medicine | radiotherapy | Brain metastases | prognosis | stereotactic radiosurgery | COST-EFFECTIVENESS | PARTITIONING ANALYSIS RPA | RADIATION-THERAPY | TRIAL | ONCOLOGY | NEUROCOGNITIVE FUNCTION | RANDOMIZED PHASE-III | ACCELERATED-FRACTIONATION | SINGLE METASTASES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Non-Small-Cell Lung - radiotherapy | Gastrointestinal Neoplasms | Prognosis | Age Factors | Humans | Middle Aged | Lung Neoplasms | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - secondary | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Karnofsky Performance Status | Small Cell Lung Carcinoma - radiotherapy | Retrospective Studies | Brain Neoplasms - radiotherapy | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms | Brain Neoplasms - diagnosis | Melanoma - radiotherapy | Treatment Outcome | Brain Neoplasms - drug therapy | Melanoma - secondary | Carcinoma, Renal Cell - radiotherapy | Analysis of Variance | Carcinoma, Renal Cell - secondary | Melanoma - drug therapy | Skin Neoplasms | Selection Bias | Aged | Combined Modality Therapy - methods | Carcinoma, Non-Small-Cell Lung - drug therapy | Care and treatment | Metastasis | Patient outcomes | Analysis | Index Medicus | SURGERY | METASTASES | NERVOUS SYSTEM | CENTRAL NERVOUS SYSTEM | MEDICINE | NUCLEAR MEDICINE | ORGANS | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | BRAIN | RADIOLOGY
Journal Article
Cell, ISSN 0092-8674, 03/2014, Volume 156, Issue 6, pp. 1298 - 1311
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 663 - 671
Journal Article
Cancer Research, ISSN 0008-5472, 09/2017, Volume 77, Issue 18, pp. 4809 - 4822
Dissociation from epithelial sheets and invasion through the surrounding stroma are critical early events during epithelial cancer metastasis. Here we find... 
TRANSCRIPTION FACTORS | BREAST-CANCER | NUCLEAR-ORGANIZATION | PERICELLULAR PROTEOLYSIS | EPITHELIAL-CELLS | ETS PROTEIN | ONCOLOGY | COLLECTIVE INVASION | BONE-MARROW | GENE-EXPRESSION | FACTORS PU.1 | Cell Proliferation | Prognosis | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Carcinoma, Lewis Lung - secondary | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Biomarkers, Tumor | Intercellular Junctions | Small Cell Lung Carcinoma - secondary | DNA-Binding Proteins - metabolism | Small Cell Lung Carcinoma - metabolism | Adenocarcinoma - metabolism | Carcinoma, Non-Small-Cell Lung - secondary | Adenocarcinoma - genetics | Tumor Cells, Cultured | Claudin-2 - metabolism | Claudin-2 - genetics | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Neoplasm Invasiveness | Mice, Inbred C57BL | Carcinoma, Non-Small-Cell Lung - metabolism | Small Cell Lung Carcinoma - genetics | Transcription Factors - genetics | Carcinoma, Lewis Lung - metabolism | DNA-Binding Proteins - genetics | Adenocarcinoma - secondary | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Animals | Carcinoma, Lewis Lung - genetics | Carcinoma, Squamous Cell - secondary | Mice | Neoplasm Staging | Apoptosis | Vimentin | Repressing | Chromatin | Transcription factors | Mesenchyme | Invasiveness | Lung | Lung cancer | Stroma | Metastasis | Tissues | E-cadherin | Mimicry | Metastases | Lymphocytes B | Lymphocytes | Tumors | Cancer | Index Medicus
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2011, Volume 6, Issue 3, pp. 576 - 582
The aim of this prospective, observational, multicenter study was to examine the epidemiology and management costs of bone metastatic disease (BMD) in patients... 
Zoledronic acid | Costs | Bone metastases | Non-small cell lung cancer | Biphosphonates | SURVIVAL | SOLID TUMORS | PHASE-III | BREAST-CANCER | ONCOLOGY | RESPIRATORY SYSTEM | PROSTATE-CANCER | DISEASE | SKELETAL-RELATED EVENTS | DOUBLE-BLIND | COMPLICATIONS | Markov Chains | Prospective Studies | Bone Neoplasms - therapy | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Bone Neoplasms - epidemiology | Lung Neoplasms - pathology | Male | Small Cell Lung Carcinoma - secondary | Carcinoma, Large Cell - secondary | Carcinoma, Large Cell - epidemiology | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - economics | Aged, 80 and over | Diphosphonates - therapeutic use | Female | Retrospective Studies | Radiotherapy Dosage | France - epidemiology | Carcinoma, Squamous Cell - epidemiology | Carcinoma, Non-Small-Cell Lung - epidemiology | Carcinoma, Squamous Cell - therapy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - economics | Carcinoma, Non-Small-Cell Lung - therapy | Lung Neoplasms - epidemiology | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Large Cell - economics | Cost-Benefit Analysis | Health Care Costs - statistics & numerical data | Carcinoma, Squamous Cell - secondary | Aged | Bone Neoplasms - economics | Lung Neoplasms - economics | Small Cell Lung Carcinoma - therapy | Adenocarcinoma - economics | Adenocarcinoma - epidemiology | Neoplasm Staging | Small Cell Lung Carcinoma - epidemiology | Carcinoma, Large Cell - therapy | Small Cell Lung Carcinoma - economics | Index Medicus | Life Sciences | Santé publique et épidémiologie
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2009, Volume 4, Issue 1, pp. 5 - 11
MET (Met proto-oncogene) activation either by gene amplification or mutation is implicated in various types of human cancers. For lung cancer, gene... 
Adenocarcinoma | Somatic mutation | Gene amplification | MET | Lung cancer | FACTOR-RECEPTOR GENE | CELL-LINES | SUBSET | SOMATIC MUTATIONS | KINASE DOMAIN | ONCOLOGY | SIGNALING PATHWAY | RESPIRATORY SYSTEM | C-MET | GROWTH | CARCINOMAS | EXPRESSION | Receptor, Epidermal Growth Factor - genetics | Sequence Deletion | ras Proteins - genetics | Proto-Oncogene Proteins c-cbl - metabolism | Proto-Oncogene Proteins p21(ras) | Prognosis | Alternative Splicing | Receptor, ErbB-2 - genetics | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Molecular Sequence Data | Carcinoma, Squamous Cell - surgery | Lung Neoplasms - pathology | Male | Pneumonectomy | Small Cell Lung Carcinoma - secondary | Receptors, Growth Factor - genetics | Carcinoma, Large Cell - secondary | Base Sequence | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Tumor Cells, Cultured | Lung Neoplasms - genetics | Protein Structure, Tertiary | Proto-Oncogene Proteins - metabolism | Carcinoma, Adenosquamous - surgery | Proto-Oncogene Proteins c-met | Ubiquitin-Protein Ligases - metabolism | Proto-Oncogene Proteins - genetics | Small Cell Lung Carcinoma - surgery | Gene Dosage | Small Cell Lung Carcinoma - genetics | Carcinoma, Adenosquamous - genetics | Mutation - genetics | Adenocarcinoma - secondary | Gene Amplification | Carcinoma, Large Cell - surgery | Carcinoma, Adenosquamous - secondary | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Neoplasm Staging | Adenocarcinoma - surgery | Receptors, Growth Factor - metabolism | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
Journal Article